芦可替尼 Ruxolitinib (Drug International)
芦可替尼是一种口服药物，用于治疗中高危原发性骨髓纤维化、真性红细胞增多症和类固醇耐药性移植物抗宿主病。
- The description claims that it is FDA approved and the first JAK inhibitor for treating myeloproliferative neoplasms and bone marrow fibrosis.
Specifications
- 通用名称
- ruxolitinib, 芦可替尼
- 剂型
- 片剂
- 包装
- 50片
AI Readiness
Good foundation, but some important product data is still missing.
63%